Ameriprise’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Sell |
30,880
-2,878
| -9% | -$39.4K | ﹤0.01% | 3556 |
|
|
2025
Q1 | $373K | Sell |
33,758
-15,395
| -31% | -$170K | ﹤0.01% | 3572 |
|
|
2024
Q4 | $523K | Buy |
49,153
+4,188
| +9% | +$44.6K | ﹤0.01% | 3486 |
|
|
2024
Q3 | $571K | Sell |
44,965
-110
| -0.2% | -$1.4K | ﹤0.01% | 3426 |
|
|
2024
Q2 | $756K | Sell |
45,075
-25,877
| -36% | -$434K | ﹤0.01% | 3280 |
|
|
2024
Q1 | $1.06M | Sell |
70,952
-2,009
| -3% | -$30.1K | ﹤0.01% | 3137 |
|
|
2023
Q4 | $1.09M | Sell |
72,961
-13,148
| -15% | -$197K | ﹤0.01% | 3146 |
|
|
2023
Q3 | $1.21M | Buy |
86,109
+1,069
| +1% | +$15K | ﹤0.01% | 3057 |
|
|
2023
Q2 | $880K | Buy |
85,040
+4,033
| +5% | +$41.7K | ﹤0.01% | 3226 |
|
|
2023
Q1 | $749K | Hold |
81,007
| – | – | ﹤0.01% | 3274 |
|
|
2022
Q4 | $718K | Sell |
81,007
-1,042
| -1% | -$9.24K | ﹤0.01% | 3269 |
|
|
2022
Q3 | $682K | Buy |
+82,049
| New | +$682K | ﹤0.01% | 3279 |
|